← The Wire
RLMDNasdaq
RELMADA THERAPEUTICS, INC.
Pharmaceutical Preparations · NV · CIK 1553643
Relmada Therapeutics develops novel drug formulations for bladder cancer and neurological disorders
$698M
Market cap
$6.98
Last close
+4.3%
1D
+1.3%
5D
2.3M
Volume
Price · last 39 sessions-5.8%
May 4L $5.72 · H $7.86Jun 29
272
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteMay 28, 20268-KResults of Operations · Reg FD DisclosureMay 12, 202610-QQUARTERLY REPORTMay 12, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 17, 2026DEF 14APROXY STATEMENTApr 17, 20268-KResults of Operations · Reg FD DisclosureMar 20, 202610-KANNUAL REPORTMar 19, 20268-KMaterial Agreement · Equity IssuanceMar 9, 2026424B5PROSPECTUS SUPPLEMENTJan 30, 20268-KExecutive ChangeDec 15, 20258-KResults of Operations · Reg FD DisclosureNov 13, 202510-QQUARTERLY REPORTNov 13, 20258-KMaterial Agreement · Reg FD DisclosureNov 5, 2025424B5PROSPECTUS SUPPLEMENTNov 5, 20258-KReg FD Disclosure · Company UpdateNov 4, 20258-KReg FD DisclosureSep 17, 20258-KCompany UpdateSep 16, 20258-KReg FD DisclosureSep 10, 20258-KReg FD DisclosureSep 2, 20258-KResults of Operations · Reg FD DisclosureAug 7, 202510-QQUARTERLY REPORTAug 7, 20258-KDelisting NoticeJul 23, 20258-KAgreement TerminatedJul 10, 20258-KReg FD DisclosureJun 18, 20258-KShareholder VoteMay 27, 202510-QQUARTERLY REPORTMay 12, 20258-KAuditor ChangeMay 12, 2025424B5PROSPECTUS SUPPLEMENTApr 28, 20258-KReg FD Disclosure · Company UpdateApr 28, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 11, 2025DEF 14APROXY STATEMENTApr 11, 20258-KResults of OperationsMar 27, 202510-KANNUAL REPORTMar 27, 20258-KMaterial Agreement · Equity IssuanceMar 26, 20258-KMaterial Agreement · Reg FD DisclosureFeb 6, 20258-KDelisting NoticeJan 27, 20258-KExecutive ChangeJan 6, 20258-KReg FD DisclosureDec 9, 20248-KReg FD DisclosureDec 4, 202410-QQUARTERLY REPORTNov 7, 202410-QQUARTERLY REPORTAug 7, 20248-KShareholder VoteMay 30, 202410-QQUARTERLY REPORTMay 8, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 9, 2024DEF 14APROXY STATEMENTApr 9, 20248-KResults of OperationsMar 19, 202410-KANNUAL REPORTMar 19, 20248-KExecutive ChangeJan 11, 20248-KReg FD DisclosureJan 4, 20248-KExecutive ChangeJan 3, 202410-QQUARTERLY REPORTNov 8, 20238-KResults of OperationsNov 8, 20238-KReg FD DisclosureOct 11, 20238-KCompany UpdateOct 10, 20238-KCompany UpdateOct 4, 20238-KReg FD DisclosureSep 20, 20238-KExecutive ChangeSep 6, 20238-KCompany UpdateAug 10, 20238-KResults of OperationsAug 8, 202310-QQUARTERLY REPORTAug 8, 20238-KExecutive Change · Shareholder VoteMay 25, 20238-KCompany UpdateMay 15, 20238-KResults of OperationsMay 11, 202310-QQUARTERLY REPORTMay 11, 20238-KCompany UpdateApr 19, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSMar 31, 2023DEF 14APROXY STATEMENTMar 31, 202310-KANNUAL REPORTMar 23, 20238-KResults of OperationsMar 23, 20238-KReg FD DisclosureMar 13, 2023SC 13GSCHEDULE 13GFeb 9, 20238-KExecutive Change · Material AgreementJan 17, 20238-KReg FD Disclosure · Company UpdateJan 9, 20238-KMaterial Agreement · Company UpdateJan 5, 20238-KMaterial AgreementDec 28, 2022SC 13GSC 13GDec 20, 20228-KReg FD Disclosure · Company UpdateDec 7, 20228-KCompany UpdateNov 14, 20228-KResults of Operations · Reg FD DisclosureNov 10, 202210-QQUARTERLY REPORTNov 10, 2022
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 15, 2025: 4 insiders bought $2.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Traversa SergioChief Executive Officer | Buy | 27,500 | $4.12 | $113K |
| Dec 15, 2025 | Shenouda MagedChief Financial Officer | Buy | 11,665 | $4.12 | $48K |
| Nov 5, 2025 | Shenouda MagedChief Financial Officer | Buy | 500,000 | $2.20 | $1.1M |
| Nov 5, 2025 | Traversa SergioChief Executive Officer | Buy | 272,500 | $2.20 | $600K |
| Nov 5, 2025 | Ence ChuckCAO and COO | Buy | 136,000 | $2.20 | $299K |
| Nov 5, 2025 | Kelly Paul EdwardChief Operating Officer | Buy | 90,000 | $2.20 | $198K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance